Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Volumetric comparisons of supratentorial white matter hyperintensities on FLAIR MRI in patients with migraine and multiple sclerosis.
The effect of vitamin a supplementation on biochemical parameters in multiple sclerosis patients.
Glatiramer acetate-induced acute hepatotoxicity in an adolescent with MS.
Dynamic regulatory network controlling TH17 cell differentiation.
Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab: Evidence From an Italian Spontaneous, Prospective, and Observational Study (the TY-STOP Study).
Tecfidera(®): an approach for repurposing.
Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis.
Gas6 increases myelination by oligodendrocytes and its deficiency delays recovery following cuprizone-induced demyelination.
[Evaluation and quantification of spasticity: a review of the clinical, biomechanical and neurophysiological methods].
Environmental risk factors for multiple sclerosis. Part I: the role of infection.
High dose cyclophosphamide preferentially targets naïve T (CD45/CD4/RA+) cells in CIDP and MS patients.
Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey.
Tip variant focal segmental glomerulosclerosis associated with interferon-β treatment of multiple sclerosis.
CD8(+) T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease.
Multiple sclerosis: an immune or neurodegenerative disorder?
PI(3,5)P2 biosynthesis regulates oligodendrocyte differentiation by intrinsic and extrinsic mechanisms.
Population Pharmacokinetics of Daclizumab High-Yield Process in Healthy Volunteers and Subjects with Multiple Sclerosis: Analysis of Phase I-III Clinical Trials.
Cutting Edge: Integrin α4 Is Required for Regulatory B Cell Control of Experimental Autoimmune Encephalomyelitis.
A molecular link between the active component of marijuana and Alzheimer's disease pathology.
A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder.
Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis.
CD56(bright) natural killer cells and response to daclizumab HYP in relapsing-remitting MS.
4-aminopyridine toxicity: a case report and review of the literature.
Effect of Rituximab in Patients With Leucine-Rich, Glioma-Inactivated 1 Antibody-Associated Encephalopathy.
CNS myelin wrapping is driven by actin disassembly.

Pages